NCT01901159View on ClinicalTrials.gov

A Study of RO4995819 to Assess Bioavailability and Safety in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

52

Participants

Timeline

Start Date

June 30, 2013

Primary Completion Date

November 30, 2013

Study Completion Date

November 30, 2013

Conditions
Healthy Volunteer
Interventions
DRUG

RO4995819

Oral doses of RO4995819 (tablet)

DRUG

RO4995819

Oral doses of RO4995819 (capsule)

Trial Locations (1)

35042

Rennes

All Listed Sponsors
lead

Hoffmann-La Roche

INDUSTRY

NCT01901159 - A Study of RO4995819 to Assess Bioavailability and Safety in Healthy Volunteers | Biotech Hunter | Biotech Hunter